Quality of Published Clinical Trials on Asthma

Journal of Asthma

Volumn 40, Issue 6, 2003, Pages 709-719

  Quiñones, Dolores ^a   Llorca, Javier ^a   Dierssen, Trinidad ^a,b   Delgado Rodríguez, Miguel ^a,c  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL SIERRALLANA   (Spain)

^c UNIVERSITY OF JAÉN   (Spain)

Author keywords

Asthma; Clinical trial; Quality

Indexed keywords

STEROID;

ADULT; ARTICLE; ASTHMA; CHRONIC DISEASE; CLINICAL TRIAL; DATA ANALYSIS; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PUBLICATION; QUALITY CONTROL; RATING SCALE; SAMPLING; STATISTICAL ANALYSIS;

ASTHMA; HUMANS; PUBLISHING; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; STATISTICS;

EID: 0142085630     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120023494     Document Type: Article

References (43)

1. CDC. Asthma mortality - Illinois: 1979-1994. Morb Mortal Wkly Rep 1998; 47:522-525.
2. Lai CK, Chan JK, Chan A, Wong G, Ho A, Choy D, Lan J, Leung R. Comparison of the ISAAC video questionnaire (AVQ3.0) with the ISAAC written questionnaire for estimating asthma associated with bronchial hyperreactivity. Clin Exp Allergy 1997; 27:540-545.
3. Peat JK, Toelle BG, Gray EJ, Haby MM, Belousova E, Mellis CM, Woolcock AJ. Prevalence and severity of childhood asthma and allergic sensitisation in seven climatic regions of New South Wales. Med J Aust 1995; 163:22-26.
4. Rimpelÿa AH, Savonius B, Rimpelÿa MK, Haahtela T. Asthma and allergic rhinitis among Finnish adolescents in 1977-1991. Scand J Soc Med 1995; 23:60-65.
5. Strachan DP, Anderson HR, Limb ES, O'Neill A, Wells N. A national survey of asthma prevalence, severity and treatment in Great Britain. Arch Dis Child 1994; 70:174-178.
6. Charpin D, Raherison C, Dutan H, Taytard A. Rev Mal Respir 2000; 17:139-158.
7. European Community Respiratory Health Survey. Variation in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECHRS). Eur Respir J 1996; 9:687-695.
8. Programa Zyterigon-Data 2000. Dirección y realización: Gabinete de Estudios Sociológicos Bernard Krief. Colaboración: SEAIC, Instituto UCB de Alergia. Macro-estudio epidemiológico. Libro Blanco. La alergia en la práctica diaria del médico de asistencia primaria y en la farmacia. Patologías alérgicas de mayor alcance social. 1999.
9. Burt CW, Knapp DE. Ambulatory care visits for asthma: United States, 1993-1994. Advanced Data Report 1996; 27:1.
10. Ojeda-Casas J. Asma infantil: presente y futuro. Rev Esp de Alergologia e Inmunol Clínica 1999; 14:179-182.
11. Inman WHW, Adelstein AM. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet 1969; ii:280-285.
12. Speizer FE, Doll R, Heaf P, Strang LB. Investigation into use of drugs preceding death from asthma. Br Med J 1968; 1:339-343.
13. British Thoracic Association. Death from asthma in two regions of England. Br Med J 1982; 285:1251-1255.
14. Jackson RT, Beaglehole R, Rea HH, Sutherland DF. Mortality from asthma: a new epidemic in New Zealand. Br Med J 1982; 285: 771-774.
15. Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax 1986; 41:833-839.
16. Campbell DA, McLennan G, Coates JR, Frith PA, Gluyas PA, Latimer KM, et al. A comparison of asthma deaths and near fatal asthma attacks in South Australia. Eur Respir J 1994; 7:490-497.
17. de Diego Damiá A. Nuevos fármacos en el tratamiento del asma. Arch Bronconeumol 1996; 32:357-365.
18. Begg C, Cho MK, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KE, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. JAMA 1996; 276:637-640.
19. Chalmers TC, Smith H Jr, Balckburn B, Silverman B A method for assessing the quality of a randomized control trial. Control Clin Trials 1981; 2:31-49.
20. Cho MK, Bero LA. Instruments for assessing the quality of drug studies published in the Medical Literature. JAMA 1994; 272:101-105.
21. DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials. N Engl J Med 1982; 306:1332-1337.
22. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992; 45:255-265.
23. Evans RW, Pollock AV. A score system for evaluating random control clinical trials of prophylasis of abdominal surgical wound infections. British Journal Surgery 1985; 72:256-260.
24. Fowkes FGR, Fulton PM. Critical appraisal of published research: introductory guidelines. Br Med J 1991; 302:1136-1140.
25. García López FJ. Impacto de la normativa legal en la calidad de los ensayos clínicos realizados en España. Med Clin (Barc) 1993; 100:770-777.
26. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports or randomized clinical trials: is blinding necessary? Control clin Trials 1996; 17:1-12.
27. Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controled trials. Lancet 1997; 350:834-843.
28. Sacristán JA, Soto J, Galende I. Evaluación crítica de ensayos clínicos. Med Clin (Barc) 1993; 100:780-787.
29. The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272:1926-1932. Correction: JAMA 1995; 273:776.
30. The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272:1926-1932. Correction: JAMA 1995; 273:776.
31. Moher D, Fortin P, Jadad AR, Jüni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996; 347:363-366.
32. Kjaergard LL, Nikolova D, Gluud C. Randomized clinical trials in Hepatology: predictors of quality. Hepatology 1999; 30:1134-1138.
33. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, Stevens R. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. Br Med J 2000; 320:537-540.
34. Scherer RW, Crawley B. Reporting of randomized clinical trials descriptors and use of structured abstracts. JAMA 1998; 280:269-272.
35. Mihan L, Windeler J. Methodological quality of controlled studies in the "medizinesche Klinik" journal. Analysis of contributions appearing between 1979 and 1996. Med Klin 1999; 94:1-8.
36. Linde K, Scholz M, Ramirez G, Clausius N, Melchart D, Jonas WB. Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol 1999; 52:631-636.
37. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355:1064-1069.
38. Gluud C, Nikolova D. Quality assessment of reports on clinical trials in the Journal of Hepatology. J Hepatol 1998; 29:321-327.
39. Ruiz-Canela M, Martínez-González MA, Gómez-Gracia E, Fernández-Crehuet J. Informed consent and approval by institutional review boards on published reports on clinical trials (letter). N Engl J Med 1999; 340:1114-1115.
40. Delgado Rodríguez M, Ruiz-Canela M, de Irala Estévez J, Llorca Diaz J, Martínez González MA. Diferencias en la calidad de los ensayos clínicos españoles publicados en revistas internacionales y los aparecidos en revistas generales de medicina de gran difusión. Rev Clin Esp 2001; 201:437-443.
41. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282: 1054-1060.
42. Delgado-Rodríguez M, Ruiz-Canela M, Irala J, Llorca J, Martínez-González MA. Participation of epidemiologists and/or biostatisticians and methodological quality of published controlled clinical trials. Journal of Epidemiology and Community Health 2001; 55569-55572.
43. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357:1191-1194.